These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12536942)

  • 1. [Bladder cancer. Clinical cases].
    Zerbib M; Bouchot O
    Prog Urol; 2002 Nov; 12(5):1167-78. PubMed ID: 12536942
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer of the urinary bladder: prognosis of the course].
    Zimichev AA; Prianichnikov MB; Maklakov VN
    Urologiia; 2009; (4):48-51. PubMed ID: 19824384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of flow cytometry in diagnosis of urinary bladder cancer].
    Bozhenko VK; Kaprin AD; Kostin AA; Kulinich TM; Kudinova EA; Chazova NL; Mel'nikova NV; Nesterov PV
    Vopr Onkol; 2007; 53(4):468-72. PubMed ID: 17969413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infiltrating bladder cancer: clinical case].
    Castel-Kremer E; Droz JP
    Rev Prat; 2009 Mar; 59(3):359-60. PubMed ID: 19408879
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of preserving therapy of invasive cancer of the urinary bladder].
    Matveev BP; Sallum SD; Kamolov BSh; Figurin KM; Matveev VB; Volkova MI
    Urologiia; 2005; (6):3-6. PubMed ID: 16419470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel blood biomarkers of human urinary bladder cancer.
    Osman I; Bajorin DF; Sun TT; Zhong H; Douglas D; Scattergood J; Zheng R; Han M; Marshall KW; Liew CC
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3374-80. PubMed ID: 16740760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topic of cancer. Clinical comments and critique of an audit of urinary bladder tumors.
    Fifer WR
    QRB Qual Rev Bull; 1977 Jan; 3(1):11-9. PubMed ID: 402621
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of urinary NMP22 (nuclear matrix protein 22) bladder chek in the detection of patients with bladder cancer].
    Kitsukawa S; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T; Matsumoto T; Aizawa T; Noda K; Ito T
    Hinyokika Kiyo; 2006 Mar; 52(3):167-72. PubMed ID: 16617867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
    Yu J; Zhu T; Wang Z; Zhang H; Qian Z; Xu H; Gao B; Wang W; Gu L; Meng J; Wang J; Feng X; Li Y; Yao X; Zhu J
    Clin Cancer Res; 2007 Dec; 13(24):7296-304. PubMed ID: 18094410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitional cell carcinoma of the urinary bladder: a clinicopathological study.
    Matalka I; Bani-Hani K; Shotar A; Bani Hani O; Bani-Hani I
    Singapore Med J; 2008 Oct; 49(10):790-4. PubMed ID: 18946612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition.
    Mao Y; Zhao X; Wang S; Cheng Y
    Anal Chim Acta; 2007 Aug; 598(1):34-40. PubMed ID: 17693304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.
    Nagao K; Itoh Y; Fujita K; Fujime M
    Int J Urol; 2007 Sep; 14(9):795-9. PubMed ID: 17760744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancies between cytology, cystoscopy and biopsy in bladder cancer detection after Bacille Calmette-Guerin intravesical therapy.
    Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
    Int J Urol; 2009 Feb; 16(2):192-5. PubMed ID: 19054166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bladder neoplasms].
    Barnaud P; Guillotreau J; Mackoumbou A
    Soins Pathol Trop; 1981 Dec; (32):23-5. PubMed ID: 6917442
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical analysis of double cancer involving bladder and prostate].
    Yumura Y; Oogo Y; Takase K; Kato Y; Hamano A; Noguchi S; Fukuda M; Satomi Y
    Hinyokika Kiyo; 2006 Apr; 52(4):255-8. PubMed ID: 16686351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP; McKenney JK; Epstein JI; Amin MB
    Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ductal cytofluorometry of urine sediment level in the diagnosis of bladder cancer].
    Kaprin AD; Bozhenko VK; Kulinich TM; Nesterov PV; Kostin AA
    Vopr Onkol; 2006; 52(5):579-81. PubMed ID: 17168371
    [No Abstract]   [Full Text] [Related]  

  • 18. Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI).
    Gilbert SM; Wood DP; Dunn RL; Weizer AZ; Lee CT; Montie JE; Wei JT
    Cancer; 2007 May; 109(9):1756-62. PubMed ID: 17366596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases.
    Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
    Int J Urol; 2009 Mar; 16(3):293-8. PubMed ID: 19207607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of bacillus Calmette-Guérin instillation therapy for carcinoma in situ of urinary bladder.
    Takenaka A; Yamada Y; Miyake H; Hara I; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):309-13. PubMed ID: 18380817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.